Thrivent Financial for Lutherans
ASMB icon

Thrivent Financial for Lutherans’s Assembly Biosciences ASMB Stock Holding History

Thrivent Financial for Lutherans’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,479
Closed -$292K – 2465
2020
Q3 		$292K Sell
1,479
-17
-1% -$4.28K ﹤0.01% 2192
2020
Q2 		$419K Hold
1,496
– – ﹤0.01% 1981
2020
Q1 		$266K Buy
+1,496
New +$321K ﹤0.01% 2035

Other funds holding ASMB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Thrivent Financial for Lutherans's ASMB Position: Q4 2020 in Review

Thrivent Financial for Lutherans sold out of Assembly Biosciences (ASMB) in Q4 2020, closing a stake of 1,479 shares — an estimated $292K sold.

Thrivent Financial for Lutherans first reported a position in ASMB in Q1 2020 and held it in 3 quarters. The position peaked at $419K in Q2 2020. 109 funds tracked by Wall St. Rank hold ASMB as of Q4 2020.

  • Thrivent Financial for Lutherans reported no remaining Assembly Biosciences position as of Q4 2020 after selling out during the quarter.
  • Thrivent Financial for Lutherans sold 1,479 Assembly Biosciences shares in Q4 2020, an estimated $292K.
  • Thrivent Financial for Lutherans first reported a position in Assembly Biosciences in Q1 2020 and held it in 3 quarters.
  • Thrivent Financial for Lutherans's Assembly Biosciences position peaked at $419K in Q2 2020.
  • 109 funds tracked by Wall St. Rank held Assembly Biosciences as of Q4 2020.

Based on Thrivent Financial for Lutherans's 13F filing for Q4 2020, filed 16 Feb 2021.